XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net increase (decrease) in net assets resulting from operations $ 3,568,484 $ (3,794)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net realized (gain) loss from investments 210,767 0
Net change in unrealized (appreciation) depreciation from investments (509,116) 9,508
Net (accretion of discounts) and amortization of premiums (301,558) (9,508)
Purchase of investments (8,442,000) (24,417,500)
PIK interest capitalized (62,587) 0
Proceeds from sales of investments and principal repayments 1,690,000 0
(Increase)/Decrease in operating assets:    
Prepaid expenses (147,334) (207,249)
Interest receivable 967,713 (66,090)
Deferred offering costs 0 1,395,059
Increase/(Decrease) in operating liabilities:    
Management fee payable 86,524 55,041
Income-based incentive fees payable 646,494 0
Capital gains incentive fee payable 5,000 0
Legal fees payable 30,249 204,251
Administrator fees payable 32,672 99,852
Valuation fees payables 93,185 0
Audit fees payable 1,183 62,250
Professional fees payable (2,438) 0
Director's fee payable (302) 35,747
Excise tax payable (80,566) 0
Due to affiliate 2,497 (383,164)
Offering cost payable 0 (1,024,256)
Organizational costs payable 0 (430,276)
Other payables (18,527) 23,406
Net cash provided by (used in) operating activities (2,229,660) (24,656,723)
Cash flows from financing activities    
Issuance of common stock, net of offering cost 0 85,269,770
Net cash provided by (used in) financing activities 0 85,269,770
Net increase (decrease) in cash & cash equivalents (2,229,660) 60,613,047
Cash & cash equivalents, beginning of period 35,125,320 5,400
Cash & cash equivalents, end of period $ 32,895,660 $ 60,618,447